Want to see IN:CAMLINFINE full AI Analyst Report?
Camlin Fine Sciences Limited (CAMLINFINE) Ratios
Camlin Fine Sciences Limited Ratios
IN:CAMLINFINE's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:CAMLINFINE's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.27 | 1.40 | 1.37 | 1.37 | 1.50 |
| Quick Ratio | 0.75 | 0.78 | 0.67 | 0.66 | 0.88 |
| Cash Ratio | 0.14 | 0.12 | 0.11 | 0.12 | 0.18 |
| Solvency Ratio | 0.07 | -0.07 | -0.01 | 0.09 | 0.11 |
| Operating Cash Flow Ratio | 0.03 | 0.03 | 0.19 | 0.06 | 0.24 |
| Short-Term Operating Cash Flow Coverage | 0.07 | 0.07 | 0.43 | 0.14 | 0.62 |
| Net Current Asset Value | $ -887.66M | $ 343.86M | $ -941.07M | $ -1.48B | $ -1.41B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.34 | 0.35 | 0.39 | 0.36 |
| Debt-to-Equity Ratio | 0.69 | 0.76 | 0.79 | 0.98 | 0.86 |
| Debt-to-Capital Ratio | 0.41 | 0.43 | 0.44 | 0.49 | 0.46 |
| Long-Term Debt-to-Capital Ratio | 0.23 | 0.23 | 0.28 | 0.33 | 0.34 |
| Financial Leverage Ratio | 2.23 | 2.24 | 2.26 | 2.51 | 2.41 |
| Debt Service Coverage Ratio | 0.22 | 0.39 | 0.11 | 0.34 | 0.54 |
| Interest Coverage Ratio | 0.38 | 1.21 | 1.03 | 3.40 | 2.94 |
| Debt to Market Cap | 0.36 | 0.22 | 0.40 | 0.36 | 0.33 |
| Interest Debt Per Share | 41.47 | 45.62 | 44.21 | 49.52 | 50.94 |
| Net Debt to EBITDA | 6.12 | 2.96 | 12.36 | 3.84 | 3.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 28.20% | 46.69% | 41.27% | 50.01% | 45.12% |
| EBIT Margin | 1.42% | 7.88% | -1.87% | 7.23% | 8.77% |
| EBITDA Margin | 5.54% | 11.71% | 3.06% | 10.94% | 12.76% |
| Operating Profit Margin | 1.42% | 8.96% | 4.47% | 9.63% | 7.55% |
| Pretax Profit Margin | -1.86% | 2.97% | -6.22% | 4.78% | 6.69% |
| Net Profit Margin | 1.60% | -8.34% | -5.82% | 3.10% | 4.32% |
| Continuous Operations Profit Margin | -1.83% | 2.96% | 3.32% | 2.37% | 4.30% |
| Net Income Per EBT | -86.37% | -281.07% | 93.46% | 64.83% | 64.57% |
| EBT Per EBIT | -130.55% | 33.14% | -139.13% | 49.62% | 88.62% |
| Return on Assets (ROA) | 1.19% | -6.87% | -4.75% | 2.53% | 3.37% |
| Return on Equity (ROE) | 2.65% | -15.42% | -10.73% | 6.36% | 8.11% |
| Return on Capital Employed (ROCE) | 1.82% | 12.68% | 5.85% | 12.78% | 8.80% |
| Return on Invested Capital (ROIC) | 1.39% | 9.52% | 4.59% | 4.88% | 4.71% |
| Return on Tangible Assets | 1.34% | -7.07% | -4.90% | 2.61% | 3.52% |
| Earnings Yield | 1.51% | -4.63% | -5.66% | 2.39% | 3.25% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.04 | 4.93 | 5.40 | 5.34 | 4.61 |
| Payables Turnover | 2.45 | 2.36 | 2.89 | 2.93 | 4.84 |
| Inventory Turnover | 2.46 | 1.69 | 1.83 | 1.49 | 3.05 |
| Fixed Asset Turnover | 2.62 | 2.53 | 1.99 | 2.02 | 1.90 |
| Asset Turnover | 0.74 | 0.82 | 0.82 | 0.82 | 0.78 |
| Working Capital Turnover Ratio | 5.77 | 5.50 | 5.66 | 5.67 | 4.56 |
| Cash Conversion Cycle | 90.02 | 135.56 | 140.83 | 189.29 | 123.46 |
| Days of Sales Outstanding | 90.45 | 74.08 | 67.56 | 68.31 | 79.20 |
| Days of Inventory Outstanding | 148.61 | 216.46 | 199.77 | 245.65 | 119.75 |
| Days of Payables Outstanding | 149.03 | 154.98 | 126.49 | 124.67 | 75.49 |
| Operating Cycle | 239.06 | 290.53 | 267.33 | 313.96 | 198.95 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.29 | 1.51 | 8.17 | 2.97 | 10.86 |
| Free Cash Flow Per Share | -1.75 | -0.89 | 4.61 | -5.45 | -5.10 |
| Dividend Paid and CapEx Coverage Ratio | 0.43 | 0.63 | 1.57 | 0.32 | 0.68 |
| Capital Expenditure Coverage Ratio | 0.43 | 0.63 | 2.29 | 0.35 | 0.68 |
| Operating Cash Flow Coverage Ratio | 0.03 | 0.04 | 0.20 | 0.06 | 0.23 |
| Operating Cash Flow to Sales Ratio | 0.01 | 0.02 | 0.09 | 0.03 | 0.10 |
| Free Cash Flow Yield | -1.80% | -0.52% | 4.78% | -4.28% | -3.66% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 66.39 | -21.58 | -17.68 | 41.89 | 30.78 |
| Price-to-Sales (P/S) Ratio | 1.06 | 1.80 | 1.03 | 1.30 | 1.33 |
| Price-to-Book (P/B) Ratio | 1.76 | 3.33 | 1.90 | 2.66 | 2.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -55.44 | -190.82 | 20.91 | -23.37 | -27.33 |
| Price-to-Operating Cash Flow Ratio | 74.92 | 112.28 | 11.80 | 42.89 | 12.84 |
| Price-to-Earnings Growth (PEG) Ratio | -0.56 | -0.52 | 0.07 | -1.63 | 2.43 |
| Enterprise Value Multiple | 25.34 | 18.33 | 45.99 | 15.70 | 13.43 |
| Enterprise Value | 24.18B | 35.78B | 22.43B | 28.90B | 24.06B |
| EV to EBITDA | 25.34 | 18.33 | 45.99 | 15.70 | 13.43 |
| EV to Sales | 1.40 | 2.15 | 1.41 | 1.72 | 1.71 |
| EV to Free Cash Flow | -73.08 | -227.53 | 28.60 | -30.93 | -35.21 |
| EV to Operating Cash Flow | 98.76 | 133.88 | 16.14 | 56.77 | 16.54 |
| Tangible Book Value Per Share | 39.03 | 46.32 | 46.83 | 44.25 | 51.44 |
| Shareholders’ Equity Per Share | 55.01 | 51.11 | 50.81 | 47.84 | 55.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.00 | -0.06 | 0.50 | 0.36 |
| Revenue Per Share | 91.07 | 94.47 | 93.72 | 98.18 | 104.85 |
| Net Income Per Share | 1.46 | -7.88 | -5.45 | 3.04 | 4.53 |
| Tax Burden | -0.86 | -2.81 | 0.93 | 0.65 | 0.65 |
| Interest Burden | -1.31 | 0.38 | 3.33 | 0.66 | 0.76 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| SG&A to Revenue | 0.27 | 0.13 | 0.03 | 0.02 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | -0.89 | -36.91 | -1.50 | 0.63 | 1.55 |
Currency in INR
